WHO ICTRP trial
A Phase 3 study to evaluate the Efficacy and Safety on Tralokinumab in Adults…
EUCTR2014-001391-54-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-001391-54-BE |
|---|---|
| Public title | A Phase 3 study to evaluate the Efficacy and Safety on Tralokinumab in Adults and Adolescents with oral corticosteroid dependent asthma. |
| Scientific title | A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid Use in Adults and Adolescents with Oral Corticosteroids dependent Asthma (TROPOS) - TROPOS |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;United States;Poland;Belgium;Netherlands;Germany |
| Conditions | Asthma MedDRA version: 18.1 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] |
| Interventions | Product Name: Tralokinumab Product Code: CAT-354 Pharmaceutical Form: Solution for injection in pre-filled syringe INN or Proposed INN: Tralokinumab CAS Number: 1044515-88-9 Current Sponsor code: CAT-354 Other descriptive name: Tralokinumab… |
| Registration date | Jan 27, 2015 |
| Target size | 120 |
| Secondary IDs | D2210C00013;NCT02281357;2014-001391-54-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: